|
Sorted by: Date | Top Results
|
|
Author |
|
Date |
| |
| |
| 1. |
Re: Did you know DDSS is guranteed FDA approval 
and that idiots will continue to post ridiculous p
ositions...
Business & Finance > Investments > Stocks (A to Z) > Stocks L >
Labopharm Inc.
|
|
Brymel |
|
14-Dec-09 12:32 pm |
| |
| 2. |
Re: Lomitapide (Toxicity!!)
I thought the numbers looked good/better than Isis
in a the phase II and the on-going phase III. am not
sure which to studies you referring to...
Business & Finance > Investments > Stocks (A to Z) > Stocks I >
ISIS Pharmaceuticals (ISIS)
|
|
Brymel |
|
18-Nov-09 03:36 pm |
| |
| 3. |
Re: The company knows FDA will give class 2 response
Where did you read that the plant had to be re-inspected
?
Business & Finance > Investments > Stocks (A to Z) > Stocks L >
Labopharm Inc.
|
|
Brymel |
|
26-Aug-09 02:49 pm |
| |
| 4. |
Re: Don&&39;t Quite understand..
Angelini is an Italian Manufacturer - they invented
Trazadone chloride, and maunfacture the latter on
behalf of pharma: <a href=\"http://www.angelini.it/\"
rel=\"nofollow\">http://www.angelini.it/
Probably should...
Business & Finance > Investments > Stocks (A to Z) > Stocks L >
Labopharm Inc.
|
|
Brymel |
|
20-Jul-09 04:42 pm |
| |
| 5. |
Re: Dummies, this is like DDSS is approved in a few weeks!"
Big mouth - but no facts. Class 1 response is 60 days
or less; class 2 response is 6 months or less. Look
it up on the FDA site...I won't bother calling
you...
Business & Finance > Investments > Stocks (A to Z) > Stocks L >
Labopharm Inc.
|
|
Brymel |
|
20-Jul-09 02:05 pm |
| |
| 6. |
Re: Manufacturing issue is a huge problem
not will nor won't - sounds more like an approvable
letter - but then again I don't pretend to read
into the future.
Business & Finance > Investments > Stocks (A to Z) > Stocks L >
Labopharm Inc.
|
|
Brymel |
|
20-Jul-09 10:58 am |
| |
| 7. |
Re: Manufacturing issue is a huge problem
Manufacturing is a problem but not a huge problem.
Unlikely that the FDA is playing games, they are too
busy. Approval is likey after submission of response.
key...
Business & Finance > Investments > Stocks (A to Z) > Stocks L >
Labopharm Inc.
|
|
Brymel |
|
20-Jul-09 10:51 am |
| |
| 8. |
Re: ddss will tank today like i said last week
"prediction" - Predicting a FDA outcome and
response are an act of faith - there is little intellectual
requirement in spewing "Monday afternoon"
"Wednesday morning". You get...
Business & Finance > Investments > Stocks (A to Z) > Stocks L >
Labopharm Inc.
|
|
Brymel |
|
20-Jul-09 07:24 am |
| |
| 9. |
Re: too much miisinformation here. Let me make it clear.
Typically ? Tramadol was announced the same day - look
it up Francis - 12/30/08 - got it ?
Business & Finance > Investments > Stocks (A to Z) > Stocks L >
Labopharm Inc.
|
|
Brymel |
|
19-Jul-09 10:54 pm |
| |
| 10. |
Re: FDA approval = 50%
you are such a genius, I admire your insights and your
calm demeanor. Happy ?
Business & Finance > Investments > Stocks (A to Z) > Stocks L >
Labopharm Inc.
|
|
Brymel |
|
18-Jul-09 01:15 pm |
| |
| 11. |
Re: Slam Dunk Approval!!!
never heard of a "slam dunk approval" ? What
is it ?
Business & Finance > Investments > Stocks (A to Z) > Stocks L >
Labopharm Inc.
|
|
Brymel |
|
7-Jul-09 02:23 pm |
| |
| 12. |
Re: In my opinion I feel the repayment of the loan from Herc is
You are funny !
Business & Finance > Investments > Stocks (A to Z) > Stocks L >
Labopharm Inc.
|
|
Brymel |
|
29-Jun-09 10:19 am |
| |
| 13. |
Re: Aegerion&&39;s MTP-i reduces LDL 48%
Willing to take a chance on that ....
Business & Finance > Investments > Stocks (A to Z) > Stocks I >
Isis Pharmaceuticals, Inc.
|
|
Brymel |
|
26-Jun-09 10:17 am |
| |
| 14. |
Re: Aegerion&&39;s MTP-i reduces LDL 48%
Agreed on burden of proof. MTP and Isis are in the
clinic not the lab. You do understand the difference
?
Business & Finance > Investments > Stocks (A to Z) > Stocks I >
Isis Pharmaceuticals, Inc.
|
|
Brymel |
|
26-Jun-09 10:17 am |
| |
| 15. |
Re: Aegerion&&39;s MTP-i reduces LDL 48%
Am neither a junior lawyer nor a junior researcher.
Though, you know that you go to market with the dosage
prescribed in the phase III. So it really is a comparaison
of oranges versus...
Business & Finance > Investments > Stocks (A to Z) > Stocks I >
Isis Pharmaceuticals, Inc.
|
|
Brymel |
|
26-Jun-09 09:43 am |
| |
| 16. |
Re: Aegerion&&39;s MTP-i reduces LDL 48%
am not sure if you are asking questions or making statements.
FDA controlled trials indicate better safety and tolerability
and no...
Business & Finance > Investments > Stocks (A to Z) > Stocks I >
Isis Pharmaceuticals, Inc.
|
|
Brymel |
|
25-Jun-09 11:02 pm |
| |
| 17. |
Re: Aegerion&&39;s MTP-i reduces LDL 48%
Also lab is a lame measurement, but I think you meant
to state clinic. I know all this is pretty complicated
and I understand your confusion....
Business & Finance > Investments > Stocks (A to Z) > Stocks I >
Isis Pharmaceuticals, Inc.
|
|
Brymel |
|
25-Jun-09 08:57 pm |
| |
| 18. |
Re: Aegerion&&39;s MTP-i reduces LDL 48%
mmm MTP inhibitors are on the market under compassionate
use exception granted by the FDA. What does that tell
you about efficacy ? New England Journal of Medicine
has...
Business & Finance > Investments > Stocks (A to Z) > Stocks I >
Isis Pharmaceuticals, Inc.
|
|
Brymel |
|
25-Jun-09 08:55 pm |
| |
| 19. |
Re: Aegerion&&39;s MTP-i reduces LDL 48%
Does it not strike you as odd that you are claiming
that ISIS has 100's of people on this drug while
the ENTIRE HoFH US population is less than 300 ?
Business & Finance > Investments > Stocks (A to Z) > Stocks I >
Isis Pharmaceuticals, Inc.
|
|
Brymel |
|
25-Jun-09 03:08 pm |
| |
| 20. |
Re: Aegerion&&39;s MTP-i reduces LDL 48%
10 person trial in HoFh - Isis has 25. Aegerion also
conducted a 460 Phase II trial in 12/08, result published
in New England Journal of Medicine. You are free to
get your "objective"...
Business & Finance > Investments > Stocks (A to Z) > Stocks I >
Isis Pharmaceuticals, Inc.
|
|
Brymel |
|
25-Jun-09 02:54 pm |
| |